Fresenius Medical Care AG & Co KGaA at JPMorgan Healthcare Conference Transcript
Great. Good morning, everybody. I'm David Adlington, Head of the European Medtech research team for JPMorgan. It's my pleasure to introduce Helen Giza, CEO of Fresenius Medical. There will be an opportunity for questions after the presentation. Thanks. Helen.
Thank you, David, and good morning, everyone. It's great to be back in person after 2 years of remote participation. And it's also my first conference as CEO of Fresenius Medical Care. I joined the company 3 years ago and have worn a number of hats over those past 3 years, initially as CFO, then Chief Transformation Officer. And during that time, I feel like I've really got to know this business really well. And I think whole-heartedly I can say this patient-centric mission-driven company is a great company with great people, great assets and truly a great future. Obviously,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |